Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation
- PMID: 3141330
- PMCID: PMC5917614
- DOI: 10.1111/j.1349-7006.1988.tb00061.x
Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation
Abstract
The antitumor effect at a distant site of PSK, a Coriolus preparation, was analyzed with the double grafted tumor system in which BALB/c mice received simultaneous intradermal inoculations of Meth-A tumor in the right (10(6) cells) and left (2 x 10(5) cells) flanks and were then injected with PSK in the right-flank tumor on day 3. PSK inhibited the growth of not only the right but also the left (non-treated) tumor. Immunized spleen cells were taken from mice which had been cured by the intratumoral administration of 5 mg of PSK and were injected into the Meth-A tumor on day 3. Adoptive transfer of PSK immunized spleen cells caused the complete regression of Meth-A tumors. The effector cell activity was lost only after treatment with anti-Lyt-1 monoclonal antibody plus complement. Spleen cells and right and left regional lymph node cells prepared from PSK immunized mice were examined for Thy-1, Lyt-1, Lyt-2 and asialo GM1 phenotypes. The number of Lyt-1-positive lymphocytes increased in the right regional lymph nodes after intratumoral administration of PSK. A massive accumulation of macrophages and polymorphonuclear leukocytes was found in the right tumor and an infiltration of macrophages and Lyt-2-positive lymphocytes was found in the left (non-treated) tumor by immunohistochemical analyses. These results suggest that intratumoral administration of PSK induces Lyt-1-positive cells first in regional lymph nodes, then in the spleen, and subsequently induces macrophages and Lyt-2-positive cells in the left (non-treated) tumor, thus bringing about the regression of metastatic tumors.
References
-
- Ebina , T. , Kohya , H. , Yamaguchi , T. and Ishida , N.Antimetastatic effect of biological response modifiers in the “double grafted tumor system” . Jpn. J. Cancer Res. (Gann) , 77 , 1034 – 1042 ( 1986. ). - PubMed
-
- Tsukagoshi , S. , Hashimoto , Y. , Fujii , G. , Kobayashi , H. , Nomoto , K. and Orita , K.Krestin (PSK) . Cancer Treat. Rev. , 11 , 131 – 155 ( 1984. ). - PubMed
-
- Saito , M. , Ichimura , O. , Kataoka , M. , Moriya , Y. , Ueno , K. , Sugawara , Y. , Nanjo , M. and Ishida , N.Pronounced antitumor effect of LAK‐like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK‐432, a killed Streptococcal preparation . Cancer Immunol. Immunother. , 22 , 161 – 168 ( 1986. ). - PMC - PubMed
-
- Sakamoto , K. , Fujiwara , H. , Nakajima , H. , Yoshioka , T. , Takai , Y. and Hamaoka , T.Requirements of adherent cells for activating Lyt‐1+2− T cells as well as for functioning as antitumor effectors activated by factor(s) from Lyt‐l+2− T cells . Jpn. J. Cancer Res. (Gann) , 77 , 1142 – 1152 ( 1986. ). - PubMed
-
- Fisher , B. , Saffer , E. A. and Fisher , E. R.Comparison of concomitant and sinecomitant tumor immunity . Proc. Soc. Exp. Biol. Med. , 135 , 68 – 71 ( 1970. ). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous